William A Meyer 3rd
Overview
Explore the profile of William A Meyer 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crawford J, Penberthy L, Pinto L, Althoff K, Assimon M, Cohen O, et al.
Open Forum Infect Dis
. 2025 Jan;
12(1):ofaf021.
PMID: 39850579
Background: We developed a United States-based real-world data resource to better understand the continued impact of the coronavirus disease 2019 (COVID-19) pandemic on immunocompromised patients, who are typically underrepresented in...
2.
Bratcher A, Jones J, Meyer 3rd W, Waheed R, Yazgi H, Harris A, et al.
PLoS One
. 2025 Jan;
20(1):e0313620.
PMID: 39774376
People with immunocompromising conditions (IC) are at increased risk of severe COVID-19 and death. These individuals show weaker immunogenicity following vaccination than individuals without IC, yet immunogenicity after SARS-CoV-2 infection...
3.
Niles J, Panov A, Saparov A, Meyer 3rd W, Kaufman H
Popul Health Manag
. 2024 Aug;
27(4):284-290.
PMID: 39101828
This cross-sectional study assessed hepatitis C virus (HCV) antibody and RNA test results performed from 2016 to 2021 at a large US clinical reference laboratory. When individual patient factors (ie,...
4.
Tsang C, Tonzel J, Symum H, Kaufman H, Meyer 3rd W, Osinubi A, et al.
MMWR Morb Mortal Wkly Rep
. 2024 May;
73(21):495-500.
PMID: 38814852
No abstract available.
5.
Coudray M, Hansel S, Alesci S, Meyer 3rd W, Christenson R, Landry L, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675979
Background: Extant literature presents contradictory findings on the role of vitamin D on SARS-CoV-2 infection. Our study included an examination of the relationship between vitamin D levels and SARS-CoV-2 infection...
6.
Goguet E, Olsen C, Meyer 3rd W, Ansari S, Powers 3rd J, Conner T, et al.
Front Immunol
. 2024 Apr;
15:1287504.
PMID: 38566991
Introduction: We sought to determine pre-infection correlates of protection against SARS-CoV-2 post-vaccine inzfections (PVI) acquired during the first Omicron wave in the United States. Methods: Serum and saliva samples from...
7.
Christenson R, Hansel S, IIyasova D, Meyer 3rd W, Puckrein G, Lee L, et al.
J Appl Lab Med
. 2024 Feb;
9(3):493-501.
PMID: 38384143
Background: COVID-19 has had a devastating impact on Black, Hispanic, and other underserved, disadvantaged populations. Here anti-SARS-CoV-2 tests are characterized in disadvantaged patients to examine equivalence in US populations. Methods:...
8.
Titova E, Kan V, Lozy T, Ip A, Shier K, Prakash V, et al.
Microbiol Spectr
. 2024 Feb;
12(3):e0205023.
PMID: 38353557
Importance: The study was prompted by a desire to better assess the immune status of patients among our cancer host cohort, one of the largest in the New York metropolitan...
9.
Ly K, Niles J, Jiles R, Kaufman H, Weng M, Patel P, et al.
Public Health Rep
. 2024 Feb;
:333549231224199.
PMID: 38344828
Objectives: Hepatitis C virus (HCV) infection is the most common bloodborne infection in the United States. We assessed trends in HCV testing, infection, and surveillance cases among US adults. Methods:...
10.
Coudray M, Hansel S, Mata-McMurry L, Ilyasova D, Lee L, Chalasani N, et al.
Popul Health Manag
. 2023 Oct;
26(6):397-407.
PMID: 37843889
The Minority and Rural Coronavirus Insights Study (MRCIS) is an ongoing prospective cohort study examining health disparities associated with SARS-CoV-2 infection among medically underserved populations. This report describes procedures implemented...